International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 4 : 981-984
Research Article
Dry Eye Disease Following Cataract Surgery
 ,
 ,
Received
May 30, 2026
Accepted
June 25, 2026
Published
July 12, 2026
Abstract

Purpose: To know the changes in tear film and the presence or absence of Dry eye disease (DED) after cataract surgery

Study Design: Prospective descriptive study.

Place and Duration of Study: Govt.Medical College Baramullah Jan 2025-december 2026

Material and Methods: The baseline characteristics of 192 patients were recorded and Dry eye (DE) questionnaire was administered by a trained interviewer. Dry eye tests were performed on day 0 (baseline), day 7, 30 and day 90 after phacoemulsification under the same physical conditions by a single surgeon. SPSS version 17 was used and data analyzed for frequencies/percentages. Diagnosis was made on three of five parameters

Results: Of the 192 patients, 121 (63%) patients had dry eyes and 71 (37%) patients did not have any dry eyes. After surgery, symptoms of DE increased but all dry eye tests declined. Maximum change in both sexes was on 7th post-operative day and in those above 60 years of age. Among all patients the height of marginal tear strip was nearly 1 mm and was discarded for grading. On 30th day the tests improved gradually but interestingly preoperative values were not achieved even after sixty days.

Conclusion: DE symptoms and signs appeared within seven days which improved later on slowly.

Keywords
INTRODUCTION

Recently, emphasis has been given to dry eye disease following cataract surgery. Before surgery most cases had normal lacrimal secretions. A grooved incision can raise these symptoms during early postoperative period.

 

Damage to any part of the lacrimal functional unit results in tear film instability and ocular surface damage so dry eyes influence patient’s ocular, general health and quality of life1. Various studies have shown the DE prevalence to be 13.3% and 21.6% respectively between the ages of 43 and 86 years after 5-10 years of follow-up2. In US population, it is 5% to 17% and the incidence of dry eye after phacoemulsification was 9.8%3. In the United States alone, about 7-10 million Americans require artificial tear preparation spendingover 100 million dollars/year4.

 

Dry eyes can develop after different ocular surgeries like photorefractive keratectomy and laser-assisted in situ keratomileusis. Cataract surgeryaffects the neurogenic response and decreases tear secretions5.

Cornea has rich innervations having 44 nerve bundles entering around the limbus. Larger nerve fibers enter from 9 to 3 o’clock position6. During surgery, temporal corneal incisions reduce the corneal sensitivity7. Moreover longer the surgical time the more damage to the corneal nerves. Neurogenic inflammation and inflammatory mediators can reduce corneal sensitivity8

 

After 4 weeks, neural growth factors regenerate the subepithelial corneal neurite cells during healing process of the corneal nerves9. This explains the occurrence of DE early after surgery which then improves slowly. The aim of our study was to know tear film changes and the presence or absence of DED after cataract surgery.

 

MATERIALS AND METHODS

A prospective descriptive study was conducted at Ophthalmology department, Govt Medical College Baramullah from Jan 2025-december 2026 after taking their consent and permission from Ethical committee. First operated eyes of one hundred and ninety-two (52% males, 48% females) uncomplicated cataract patients undergoing phacoemulsification with no dry eye symptoms were included. The mean age was 60.07 years with 40-78 years range. Patients with autoimmune diseases, previous ocular surgery/injury, ocular allergies and using topical eye drops were excluded. Patients who developed complications during surgery were also excluded. Under subtenon anesthesia a standard surgical technique with 2.80 mm superior/temporal corneal incision was used on all patients. After surgery, all patients used tobramycin with dexamethasone eye drops four times daily for four weeks.

 

Clinical examinations included DE questionnaire (DEQ 5), tear film breakup time (TBUT), Shirmer’s test (ST), corneal fluorescein staining (CFS) with Oxford Schema, tear meniscus height (TMH) and slit-lamp examination of lid margin changes based on ‘The International Dry Eye Workshop’ (DEWS) 2007 guidelines by a single surgeon under same physical conditions. Follow-up was on 7th day, 1 month and 3 months postoperatively. Diagnosis was based on DEQ scores, TBUT values < 10 sec, ST values < 10 mm/5s and CFS staining > 1 and presence of lid plugging and telengiectasias. Data was entered into SPSS version 17 and analyzed for percentages/frequencies.

 

RESULTS

Of 192 subjects there were 48% females and 52% males. Majority of patients 110 (57.2%) were from urban areas and most of them, 98 (51%), belonged to age group of 53-65 years. There were 138 (72%) patients who were operated for right eye. Of the 192 patients, 121 (63%) {71 (58.6%) male and 50 (41.4%) females} patients had dry eyes and 71 (37%) patients did not have any dry eyes. The observations about the dryness of the eyes, if present, were graded according to the DEWS 2007 report. Table 1 shows the baseline characteristics of all the patients. Dry eye symptoms and severity on 7th, 30th and 90th days are shown in Table 2. At the end of the 30th post-operative day, out of 192 patients, 42 (15.4%) had improved TBUT and ST values.

Table 1. Baseline Characteristics of the Study Participants (N = 192)

Characteristic

Category

n

%

Age Group (years)

40–52

55

28.7

 

53–65

98

51.0

 

66–78

39

20.3

Sex

Male

100

52.0

 

Female

92

48.0

Residential Status

Urban

123

64.0

 

Rural

69

36.0

Operated Eye

Right eye

138

72.0

 

Left eye

54

28.0

Incision Site

Superior incision

101

52.6

 

Temporal incision

91

47.4

 

Table 2. Dry Eye (DE) Symptom Scores on 7th, 30th, and 90th Day

Ocular History

Visit 1 (7 Days) N (%)

Visit 2 (30 Days) N (%)

Visit 3 (90 Days) N (%)

Foreign body sensation

99 (51.5%)

82 (42.7%)

77 (40.0%)

Burning

98 (51.4%)

90 (46.8%)

72 (37.5%)

Dryness

81 (42.6%)

80 (41.6%)

67 (34.9%)

Watering

80 (41.6%)

78 (41.2%)

77 (40.0%)

Itching

42 (21.8%)

41 (21.6%)

35 (18.2%)

 

Table 3. Dry Eye Positive Signs on the 7th Day

Test

Incidence (%)

Tear Film Break-Up Time (TBUT)

69.0

Schirmer's Test (ST)

19.8

Oxford Schema

51.0

Lid Margin Abnormality

53.0

DEQ-5

62.0

 

Table 4. Tear Film Break-Up Time (TBUT) and Schirmer's Test Results on the 7th Day

  1. Tear Film Break-Up Time (TBUT)

TBUT Category

n

%

>15 seconds

59

30.7

<10 seconds

45

23.4

<5 seconds

88

45.8

 

  1. Schirmer's Test

Schirmer's Test Value

n

%

≥15 mm

153

80.0

<10 mm

17

8.9

<5 mm

22

11.1

 

After cataract surgery all dry eye tests values were low with increased symptoms of patients. There were 12.2% eyes which had grade 4, 21.4% eyes had grade 3, 33.6% had grade 2 and 60 eyes (30.6%) had grade 1 Oxford Schema staining. There were 88 eyes (44.8%) which showed TBUT values below 10 seconds and 45 (23%) eyes showed values < 5s. ST values were below 10 mm/5 seconds in 22 eyes (11.2%) and below 5 mm/5 sec in 17 eyes (8.6%) (Table 3).

Operating microscope related phototoxicity was observed in other study21. The light exposure caused rise of DE symptoms and signs in Cho's and Kim's11 study. In our study we did not any find relationship between microscopic light exposure time and DE tests.

Movahedan et al.22 mentioned that a healthy ocular surface has best visual results in cataract patients. Mild to moderate DE disease may not disturb vision but severe DE disturbs the vision in patients. So a proper preoperative assessment should be done10.

The present study showed abnormal interpalpebral staining of ocular surface characteristic of DE in contrast to inferior staining which occurs in drug toxicity. The abnormal Oxford Schema grading after cataract surgery may be the result of neurogenic inflammation23.

In the present study, 101 (52.6%) cases had superior incision while 91 (47.4%) had temporal incision which showed more DE symptoms postoperatively explaining severing of corneal nerve twigs8.

Benzalkonium chloride containing topical eye drops reduce the number of mucin-expressing cells resulting in tear film instability24. Over use of drops affect corneal toxicity and dry eye after surgery. In the present study we did not find the same observations..

 

CONCLUSION

Our results revealed that Cataract surgery negatively affects the tear film parameters and ocular surface in early postoperative period thus leading to DE.

 

RECOMMENDATIONS

 

Cataract surgeons can improve their results by treating the ocular surface before and after operation.

 

REFERENCES

  1. International Dry Eye Workshop (DEWS) The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop. Ocul Surface, 2007; 5: 75–92.

  2. Han SB, Hyon JY, Woo SJ, Lee JJ, Kim TH, et al. Prevalence of dry eye disease in an elderly Korean population. Arch Ophthalmol. 2011; 129: 633–8.

  3. Luthe R. Dry eye screening and the cataract patient. Ophthalmology Management, May 2012; Vol. 16: 48-51.

  4. Galor A, Feuer W, Lee DJ. Prevalence and risk factors of dry eye syndrome in a United States Veterans Affairs population. Am J Ophthalmol. 2011; 152: 377–384.

  5. Shankar S. Ganvit H.D. Ahir , Sadhu J, Pandya NN. Study of the dry eye changes after cataract surgery Int J Res Med. 2014; 3 (2): 142-145.

  6. Al-Aqaba MA, Fares U, Suleman H, Lowe J, Dua HS. Architecture and distribution of human corneal nerves. Br J Ophthalmol. 2010; 94: 784–9.

  7. Han KE, Yoon SC, Ahn JM, Nam SM, Stulting RD, Kim EK, et al. Evaluation of dry eye and meibomian gland dysfunction after cataract surgery. Am J Ophthalmol. 2014; 157: 1144–50.

  8. Jiang Y.1., Ye H., Xu J., Lu Y. Non-invasive Keratograph assessment of tear film break-up time and location in patients with age-related cataracts and dry eye syndrome. J Int Med Res. 2014; 42 (2): 494–502.

  9. Morano M, Wrobel S, Fregnan F, Ziv-Polat O, Shahar A, Ratzka A, Grothe C, Geuna S, Haastert-Talini K. Nanotechnology versus stem cell engineering: in vitro comparison of neurite inductive potentials. Int J Nanomed. 2014; 9: 5289–5306.

  10. Sahu PK, Das GK, Malik A, Biakthangi L. Dry Eye following Phacoemulsification Surgery and its Relation to Associated Intraoperative Risk Factors Middle East Afr J Ophthalmol. 2015 Oct-Dec; 22 (4): 472–4.

  11. Cho YK, Kim MS. Dry eye after cataract surgery and associated intraoperative risk factors. Korean J Ophthalmol. 2009; 23: 65–73.

  12. Liu ZG, Li W. Dry eye relevant to ocular surgery. Zhonghua Yan Ke Za Zhi. 2009; 45: 483–5.

  13. Hawaiian Eye 2011 Meeting; Monday, February 14, 2011. Available from: http://www.cataract-surgery-information.blogspot.com/2011/02/cataract-surgery-dry-eyes-what-you-need.html. [Last accessed on 2013 Mar 02

  14. Moon H, Yoon J, Hyun S, Kim KH. Short-term influence of aspirating speculum use on dry eye after cataract surgery, 2014; 33: 373–375.

  15. Kasetsuwan N, Satitpitakul V, Changul T, Jariyakosol S. Incidence and pattern of dry eye after cataract surgery. Plos One, 2013; 8: 1–6.

  16. Khanal S, Tomlinson A, Esakowitz L, Bhatt P, Jones D, et al. Changes in corneal sensitivity and tear physiology after phacoemulsification. Ophthalmic Physiol Opt. 2008; 28: 127–34.

  17. Srinivasan R, Agarwal V, Suchismitha T, Kavitha. Dry eye after phacoemulsification. AIOC. 2008: 116-8.

  18. Oh T, Jung Y, Chang D, Chang D, Kim J, Kim H. Changes in tear film and ocular surface after cataract surgery. Jpn J Ophthalmol. 2012; 56: 113–8.

  19. Cetinkaya S, Mestan E, l Acir NO, Cetinkaya YF, Dadac Zi, Yener HI. The course of dry eye after phacoemulsification surgery. BMC Ophthalmol. 2015; 15: 68.
  20. Han KE, Yoon SC, Ahn JM, Nam SM, Stulting RD, Kim EK, et al. Evaluation of dry eye and meibomian gland dysfunction after cataract surgery. Am J Ophthalmol. 2014; 157 (6): 1144–1150.
  21. Hwang HB, Kim HS. Phototoxic effects of an operating microscope on the ocular surface and tear film. Cornea, 2014; 33 (1): 82–90.
  22. Movahedan A., Djalilian A.R. Cataract surgery in the face of ocular surface disease. Curr Opin Ophthalmol. 2012 Jan; 23 (1): 68–72.
  23. Lee H, Chung B, Kim KS, Seo KY, Choi BJ, Kim TI. Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial. Am J Ophthalmol. 2014; 158 (6): 1172–1183.
  24. Chung YW, Oh TH, Chung SK. The effect of topical cyclosporine 0.05% on dry eye after cataract surgery. Korean J Ophthalmol. 2013; 27: 167–7.
Recommended Articles
Research Article Open Access
Addressing Residual Cardiovascular Risk: Contemporary Advances in Lipid Management
2026, Volume-7, Issue 4 : 985-991
Research Article Open Access
To Evaluate the Importance of Critical View of Safety, Rouviere’s Sulcus, And Posterior Dissection in Patients of Laparoscopic Cholecystectomy
2026, Volume-7, Issue 4 : 940-954
Research Article Open Access
Effects of Digital Screen Usage on Mental Health Outcomes and Cognitive Function Among Adolescents- A Systematic Review and Meta-Analysis (2010-2025)
2026, Volume-7, Issue 4 : 932-939
Research Article Open Access
Prevalence of Anemia Among Patients with Type 2 Diabetes Mellitus Attending a Tertiary Care Hospital in Hassan, Karnataka
2026, Volume-7, Issue 1 : 3760-3763
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 4
Citations
8 Views
4 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved